Literature DB >> 33785198

Nonhomologous end joining: new accessory factors fine tune the machinery.

Dipayan Ghosh1, Sathees C Raghavan2.   

Abstract

Nonhomologous DNA end joining (NHEJ) is one of the major DNA double-strand break (DSB) repair pathways in eukaryotes. The well-known critical proteins involved in NHEJ include Ku70/80, DNA-PKcs, Artemis, DNA pol λ/μ, DNA ligase IV-XRCC4, and XLF. Recent studies have added a number of new proteins to the NHEJ repertoire namely paralog of XRCC4 and XLF (PAXX), modulator of retroviral infection (MRI)/ cell cycle regulator of NHEJ (CYREN), transactivation response DNA-binding protein (TARDBP) of 43 kDa (TDP-43), intermediate filament family orphan (IFFO1), ERCC excision repair 6 like 2 (ERCC6L2), and RNase H2. PAXX acts as a stabilizing factor for the main NHEJ components. MRI/CYREN seems to play a dual role stimulating NHEJ in the G1 phase of the cell cycle, while inhibiting the pathway in the S and G2 phases. TDP-43 can recruit the ligase IV-XRCC4 complex to the DSB sites and stimulate ligation in neuronal cells. RNase H2 excises out the ribonucleotides inserted during repair by DNA polymerase μ/TdT. This review provides a brief glimpse into how these new partners were discovered and their contribution to the mechanism and regulation of NHEJ.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DSB repair; NHEJ machinery; cell cycle; double-strand break; end joining; genomic instability; homologous recombination

Year:  2021        PMID: 33785198     DOI: 10.1016/j.tig.2021.03.001

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  11 in total

Review 1.  Polymerases and DNA Repair in Neurons: Implications in Neuronal Survival and Neurodegenerative Diseases.

Authors:  Xiaoling Li; Guanghui Cao; Xiaokang Liu; Tie-Shan Tang; Caixia Guo; Hongmei Liu
Journal:  Front Cell Neurosci       Date:  2022-06-30       Impact factor: 6.147

Review 2.  Unpicking the Roles of DNA Damage Protein Kinases in Trypanosomatids.

Authors:  Gabriel L A Silva; Luiz R O Tosi; Richard McCulloch; Jennifer Ann Black
Journal:  Front Cell Dev Biol       Date:  2021-08-06

Review 3.  RAD52: Paradigm of Synthetic Lethality and New Developments.

Authors:  Matthew J Rossi; Sarah F DiDomenico; Mikir Patel; Alexander V Mazin
Journal:  Front Genet       Date:  2021-11-23       Impact factor: 4.599

Review 4.  Role of Paralogue of XRCC4 and XLF in DNA Damage Repair and Cancer Development.

Authors:  Jialin Tang; Zhongxia Li; Qiong Wu; Muhammad Irfan; Weili Li; Xiangyu Liu
Journal:  Front Immunol       Date:  2022-03-02       Impact factor: 7.561

5.  Commentary: Kinesin Family Member C1 Increases Resistance of Glioblastoma to Temozolomide Through Promoting DNA Damage Repair.

Authors:  Liu Yang; Pingan Lu; Song Qu
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.064

Review 6.  BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside.

Authors:  Stergios Boussios; Elie Rassy; Michele Moschetta; Aruni Ghose; Sola Adeleke; Elisabet Sanchez; Matin Sheriff; Cyrus Chargari; Nicholas Pavlidis
Journal:  Cancers (Basel)       Date:  2022-08-11       Impact factor: 6.575

7.  Pan-cancer analysis of co-occurring mutations in RAD52 and the BRCA1-BRCA2-PALB2 axis in human cancers.

Authors:  Abdulaziz B Hamid; Lauren E Frank; Renee A Bouley; Ruben C Petreaca
Journal:  PLoS One       Date:  2022-09-15       Impact factor: 3.752

Review 8.  Long non‑coding RNAs interact with RNA‑binding proteins to regulate genomic instability in cancer cells (Review).

Authors:  Kai Yang; Xiaoxiang Liang; Kunming Wen
Journal:  Oncol Rep       Date:  2022-08-25       Impact factor: 4.136

Review 9.  Structural insights into the role of DNA-PK as a master regulator in NHEJ.

Authors:  Siyu Chen; James P Lees-Miller; Yuan He; Susan P Lees-Miller
Journal:  Genome Instab Dis       Date:  2021-07-23

Review 10.  Autophosphorylation and Self-Activation of DNA-Dependent Protein Kinase.

Authors:  Aya Kurosawa
Journal:  Genes (Basel)       Date:  2021-07-19       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.